Department of Pediatrics, Fuyang People's Hospital, Fuyang, China.
Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):687-693. doi: 10.26355/eurrev_202301_31071.
To analyze the clinical data and next generation sequencing (NGS) results from a child with 22q11.2 deletion syndrome (22q11DS) complicated with pulmonary alveolar proteinosis (PAP) who was admitted to the Department of Pediatrics of Fuyang People's Hospital and to present a review of the literature.
A 9-year-old male child, whose face had a small mandible and high-arched palate, but lacked a cleft palate, had repeated respiratory tract infections and bronchiectasis. Clinical examination, computer tomography, and electronic bronchoscopy were performed. Genetic testing via NGS was undertaken. PAP was confirmed by Periodic Acid Schiff staining of milky white alveolar lavage fluid isolated by electronic bronchoscopy. A deletion of approximately 2.46 Mbp on chromosome 22q11.2 was confirmed by NGS. During hospitalization, anti-infection, nebulization, alveolar lavage, and regular application of thymosin were administered to the patient. The condition of the patient stabilized following treatment.
22q11DS and PAP are both rare diseases, and the manifestation of 22q11DS combined with PAP has not been previously reported. The diagnosis and treatment of this case will be a reference for future clinical work.
分析一名患有 22q11.2 缺失综合征(22q11DS)合并肺泡蛋白沉积症(PAP)的儿童的临床数据和下一代测序(NGS)结果,该患儿入住我院儿科,并对文献进行回顾。
一名 9 岁男性患儿,面型小下颌高腭弓,但无腭裂,反复呼吸道感染和支气管扩张。行临床检查、计算机断层扫描和电子支气管镜检查。进行 NGS 基因检测。通过电子支气管镜分离的乳白色肺泡灌洗液经过碘酸希夫染色证实为 PAP。NGS 证实 22q11.2 染色体上存在约 2.46 Mbp 的缺失。患儿住院期间接受抗感染、雾化、肺泡灌洗和胸腺肽常规应用治疗。经治疗,患儿病情稳定。
22q11DS 和 PAP 均为罕见疾病,22q11DS 合并 PAP 的表现尚未见报道。本病例的诊断和治疗将为今后的临床工作提供参考。